Parallel Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17
| Closed | -$330 | – | 3490 |
|
|
2023
Q2 | $330 | Sell |
17
-108
| -86% | -$2.1K | ﹤0.01% | 3179 |
|
|
2023
Q1 | $3.55K | Buy |
125
+74
| +145% | +$2.1K | ﹤0.01% | 2549 |
|
|
2022
Q4 | $1.49K | Buy |
51
+3
| +6% | +$88 | ﹤0.01% | 2790 |
|
|
2022
Q3 | $1K | Buy |
48
+15
| +45% | +$312 | ﹤0.01% | 3038 |
|
|
2022
Q2 | $1K | Sell |
33
-19
| -37% | -$576 | ﹤0.01% | 2886 |
|
|
2022
Q1 | $3K | Sell |
52
-35
| -40% | -$2.02K | ﹤0.01% | 2513 |
|
|
2021
Q4 | $4K | Buy |
87
+44
| +102% | +$2.02K | ﹤0.01% | 2522 |
|
|
2021
Q3 | $2K | Buy |
43
+17
| +65% | +$791 | ﹤0.01% | 2742 |
|
|
2021
Q2 | $1K | Hold |
26
| – | – | ﹤0.01% | 2845 |
|
|
2021
Q1 | $1K | Sell |
26
-21
| -45% | -$808 | ﹤0.01% | 2711 |
|
|
2020
Q4 | $2K | Hold |
47
| – | – | ﹤0.01% | 2354 |
|
|
2020
Q3 | $2K | Buy |
+47
| New | +$2K | ﹤0.01% | 2346 |
|